Pfizer COVID-19 vaccine effective against coronavirus variants, study finds
Israel Ministry of Health study shows promising results for Pfizer/BioNtech against coronavirus variants
A new COVID-19 vaccine study out of Israel claims the Pfizer jabs are effective against variants, according to a new study published in a medical journal.
Two shots of Pfizer/BioNtech's vaccine delivered more than 95% protection from infection, severe illness and death, the Israel Ministry of Health reported in The Lancet.
"Two doses of BNT162b2 are highly effective across all age groups in preventing symptomatic and asymptomatic SARS-CoV-2 infections and COVID-19-related hospitalizations, severe disease, and death, including those caused by the B.1.1.7 SARS-CoV-2 variant," the study said.
B.1.1.7 is known as the variant first identified in the United Kingdom.
The study added the Pfizer vaccine provided 95.3% protection against infection and 96.7% protection against death seven days after the second dose.
Full vaccination mattered as one dose alone gave just 57.7% protection against infection, 75.7% against hospitalization, and 77% against death.
"By 14 days after vaccination, protections conferred by a second dose increased to 96.5% protection against infection, 98% against hospitalization, and 98.1% against death," the study said.
Entire article:
https://www.foxnews.com/health/pfizer-covid-19-vaccine-effective-coronavirus-variants-study